Company Overview and News

0
Credit Market Conviction: TIPS

2018-06-05 seekingalpha
Bonds or any fixed income stream of cash flow is typically negatively impacted by rising inflation. Treasury inflation-protected securities (TIPS) are a security designed to offset the negative impact of rising inflation.
IEF TIP

26
Rethinking Inflation - 3 Ways To Protect Your Portfolio

2018-05-31 seekingalpha
Traditional portfolio strategies for hedging against inflation can be effective during quickly rising or higher than expected inflation, but often provide lackluster or inconsistent returns during periods of low inflation.
BKLN VFH IYF VTIP TIP GLD EV IAU VGT VHT O87 IBB STIP ROBO

0
Treasury Floating Rates Notes: A Solid Investment When Charting Uncertain Territory

2018-05-10 seekingalpha
The iShares Treasury Floating Rate Bond is a fixed-income ETF comprised of the Treasury’s Floating Rate Note that launched in 2014.
TFLO TIP

2
Why Fear March Jobs Data? These ETFs May Gain Ahead

2018-04-09 zacks
U.S. employers added 103,000 new jobs in March, after an upwardly revised 326,000 job gains in February and falling short of market expectations of 193,000 jobs. However, job gains in January have been revised down from 239,000 to 176,000. After revision, total employment gains in January and February were 50,000 less than reported earlier.
UNP TIP

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to TIP / iShares TIPS Bond ETF on message board site Silicon Investor.

Home Theater Systems - Designs, Products, Tips and Info Jake Strawu0027s household cleaning tips
AMUT American Multiplex American MultiPlexer (AMUT) -- Cheap Now, But for How Long
Cleaning Tips For The Single Man Auto Repair u0026 Maintenance Tip
Tips for Living High from Martha Stewart Talk Smack Here/Market Tips
ONLINE VIDEO TRAINING FOR READING MULTIPLE TIME FRAMES TIPS Tianrong Internet Products u0026 Services
CUSIP: 464287176